Biotech & Pharma

Daiichi taps John Tsai to lead R&D as Ken Takeshita departs

20 sec read15 views0 listens

John Tsai, formerly of Novartis and Amgen, will lead Daiichi Sankyo's global R&D beginning in April, succeeding Ken Takeshita. This transition underscores the companyG??s commitment to innovation under new leadership, signaling potential shifts in research direction for content creators following pharmaceutical trends.

Read the full article at Endpoints News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Biotech & PharmaJun 29 sec read

Fulcrum Halts Development of SCD Candidate Pociredir, Sets Strategic Review

Unknown command: /no_think Read the full article at Genetic Engineering News Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more....

Ali Nemati

AI & Machine LearningMay 111m & 1 s read

Show HN: adamsreview - better multi-agent PR reviews for Claude Code!

you want to focus on specific parts of your codebase, you can add them for further analysis using: /add-files path/to/file1.py path/to/file2.js This command allows you to specify additional files that should be included in the review process. The p...

Ali Nemati

Health & MedicineMay 928 sec read

Opinion: RFK Jr. allegedly 'collected' a dead raccoon's penis. Was it bioethically justifiable?

Health Secretary Robert F. Kennedy Jr. is alleged to have collected a dead raccoon's penis in 2001 for later study, as detailed in Isabel Vincent’s biography. This raises significant bioethical concerns and questions about his judgment that are parti...

Ali Nemati